We would love to hear your thoughts about our site and services, please take our survey here.
"We base our price target on multiples and on the value that we believe Itaconix's differentiated, plant-based technology platform would have to an industrial third party." The broker is right, the value for the ITX technology bundle has got to be worth more than current EV implied minority value after deduction of the surplus cash on our BS. About USD90m has been invested to date in developing the IPR/assets and the original investment routemap is now definitely playing out and risk is unwinding rapidly as we grow and diversify further. Hence if anyone wanted to step in our shoes and buy ITX they would have to pay a v large premium to current mcap and the professional investors who came in earlier 2023 know this....
I think most new price sensitive material information gets put out to everyone at the same time during RNS events but I get your point and if you can into the analyst circle with a ligin then please share it!
Hi snooz, the professional analyst briefing pre Public one is to ensure an orderly stock market is maintained for your benefit and mine and so market makers can integrate any new info. Into the share prices bid / offer ranges. So it's not designed to screw over private investors
With the big pile of cash on balance sheet I'd say great buy snooz. It means you invested in the underlying business at approx 2.5p in old money. Bargain. My carry price is about that originally a few years ago and still a very strong hold for me. It's like saying majority of the historical R&D invested and patent portfolio is worth zip which we know to be untrue
I have no clue other than the seller needed the cash! Weird to sell at this point before the consol and US shr marketing campaign is weeks away that may bring some immediate gains. Just looked at the NASDAQ tech/growth stock trend last few years - surprised its held up so well over 2023. It just means the "valuation gap" between UK and US stocks generally is even bigger than it was before AIM trended southwards so the likes of ITX must be looking very cheap now from US investor relative bang for the buck perspectives. Even considering the small cap nature if AIM which also has a large discount v's other indices.
Maybe, but the strong growth story is already playing out for long term investors to see. I think the gradual uptick will come over a 4 to 6 mth period beyond consolidation as proactive investor side comms kick in state side raising private investor awareness
HOORAY indeed Smart-Inv'or. At last, makes perfect sense for US Market access and driving greater share demand into 2024 for ITX since US investors are generally much more long term savvy investors not short term day traders like many UK AIM folks.
In the context of the eventual new SP post consol. It won't matter too much since we will still prob be in low single digits US dollars and not 100 US DOLLARS per share and in sweet spot for new investors either way. Art rather than science this consol. Just need a big consol to get into flavoured zone with various US private investors.
Much of our conversations have been about today's virus configurations and mutations...but the beauty of SNG001 is its a braod AGNOSTIC platform TX rather like a dam to stop water ingress..so the TX value to society is immediate (if given early) against probably all serious emerging respiratory viruses without going to the lab to tweet a monoclonal or focused therapeutic or having to adjust your vaccine to new target episodes. Simple protection now not in 6 months time
It's great to have some specialist investors increasing. Shows they feel there is a good investment case. Re: 10m cash. It just gives greater strategic and investment optionally to move quickly to grab market opportunity and mange volume capacity uplift.